Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
International Journal of Oncology
|
May 5, 2011
Inhibition of growth of human small cell and non-small cell lung carcinomas by antagonists of growth hormone-releasing hormone (GH-RH)
J Pinski, A Schally, A Jungwirth, et al.
International Journal of Oncology
|
May 3, 2011
Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin
A Jungwirth, A Schally, A Nagy, et al.
Pflugers Archiv : European Journal of Physiology
|
July 1, 1996
Fluorescence-optical measurements of chloride movements in cells using the membrane-permeable dye diH-MEQ
E Wöll, M Gschwentner, J Fürst, et al.
The Prostate
|
August 1, 1997
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
A Jungwirth, G Galvan, J Pinski, et al.
Endocrinology
|
August 1, 1996
Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats
J Pinski, N Lamharzi, G Halmos, et al.
Renal Physiology and Biochemistry
|
January 1, 1990
Ion channels in Madin-Darby canine kidney cells
F Lang, F Friedrich, M Paulmichl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
A Jungwirth, J Pinski, G Galvan, et al.
British Journal of Urology
|
July 1, 1997
Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study
J Ramon, T H Lynch, I Eardley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 1996
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent
A Nagy, A V Schally, P Armatis, et al.
British Journal of Pharmacology
|
May 1, 1996
Blockade of swelling-induced chloride channels by phenol derivatives
M Gschwentner, A Jungwirth, S Hofer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
International Journal of Oncology
|
May 5, 2011
Inhibition of growth of human small cell and non-small cell lung carcinomas by antagonists of growth hormone-releasing hormone (GH-RH)
J Pinski, A Schally, A Jungwirth, et al.
International Journal of Oncology
|
May 3, 2011
Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin
A Jungwirth, A Schally, A Nagy, et al.
Pflugers Archiv : European Journal of Physiology
|
July 1, 1996
Fluorescence-optical measurements of chloride movements in cells using the membrane-permeable dye diH-MEQ
E Wöll, M Gschwentner, J Fürst, et al.
The Prostate
|
August 1, 1997
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
A Jungwirth, G Galvan, J Pinski, et al.
Endocrinology
|
August 1, 1996
Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats
J Pinski, N Lamharzi, G Halmos, et al.
Renal Physiology and Biochemistry
|
January 1, 1990
Ion channels in Madin-Darby canine kidney cells
F Lang, F Friedrich, M Paulmichl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
A Jungwirth, J Pinski, G Galvan, et al.
British Journal of Urology
|
July 1, 1997
Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study
J Ramon, T H Lynch, I Eardley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 9, 1996
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent
A Nagy, A V Schally, P Armatis, et al.
British Journal of Pharmacology
|
May 1, 1996
Blockade of swelling-induced chloride channels by phenol derivatives
M Gschwentner, A Jungwirth, S Hofer, et al.
Page
of 5